The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 18, 2006

Filed:

Jun. 30, 1990
Applicants:

Gustay Gaudernack, Oslo, NO;

Jon Amund Eriksen, Porsgrunn, NO;

Mona Møller, Porsgrunn, NO;

Marianne Klemp Gjertsen, Oslo, NO;

Ingvil Sæterdal, Oslo, NO;

Stein Sæbøe-larsen, Oslo, NO;

Inventors:

Gustay Gaudernack, Oslo, NO;

Jon Amund Eriksen, Porsgrunn, NO;

Mona Møller, Porsgrunn, NO;

Marianne Klemp Gjertsen, Oslo, NO;

Ingvil Sæterdal, Oslo, NO;

Stein Sæbøe-Larsen, Oslo, NO;

Assignee:

GemVax AS, Oslo, NO;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/04 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 16/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention relates to proteins or peptides that elicit T cell mediated immunity, and to cancer vaccines and compositions for anti-cancer treatment comprising such proteins or peptide fragments. This invention also relates to pharmaceutical compositions comprising the proteins or peptides and methods for generating T lymphocytes capable of recognizing and destroying tumor cells in a mammal. More specifically, a telomerase protein or peptide for use in a method of treatment or prophylaxis of cancer is provided. In a preferred embodiment, the method comprises generating a T cell response against telomerase.


Find Patent Forward Citations

Loading…